Axent

Aspen Neuroscience

This biotechnology firm develops personalised autologous cell therapies to replace damaged neurons in patients with Parkinson's disease.

Mitokinin

This biotechnology company develops small molecule drugs to treat Parkinson's disease and other neurodegenerative conditions for patients and healthcare providers.

Axo Neurotech

This company develops biohybrid neural interfaces using cultured cells and flexible electronics for patients with nervous system conditions and human-machine interaction markets.

Axoft

This company develops ultra-soft, bio-inspired brain-machine interfaces and neural implants for patients with neurological disorders such as paralysis and neurodegenerative diseases.

Mangrove

Mangrove Neuro develops cell and tissue replacement therapies, including cortical grafts, to treat neurodegeneration and brain trauma for patients.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

Herantis Pharma

This clinical-stage biotechnology company develops neurorestorative drug therapies for patients living with Parkinson's disease.

BE Therapeutics

This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.